Photo from wikipedia
Heart failure oral therapies (HFOTs), including beta‐blockers (BB), renin–angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns… Click to show full abstract
Heart failure oral therapies (HFOTs), including beta‐blockers (BB), renin–angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns have been raised because early administration of HFOTs may worsen patient's condition. We hypothesized that HFOTs at hospital discharge might be associated with better post‐discharge survival.
Journal Title: European Journal of Heart Failure
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!